Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
    Clin Toxicol (Phila). 2008 Dec;46(10):1083-4. doi: 10.1080/15563650701261488.

    Pediatric fatality secondary to EDTA chelation.

    Source

    Pittsburgh Poison Center, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA.

    Abstract

    BACKGROUND:

    Chelation therapy has emerged as a popular treatment modality to remove heavy metals that are thought to cause autism. We report a fatality that occurred as a consequence of chelation therapy for autism when the incorrect form of EDTA was administered.

    CASE REPORT:

    A five-year-old autistic male was being chelated in a physician's office. While receiving his third treatment he went into cardiac arrest. It was not determined until after the child's death that he had been given edetate disodium rather than edetate calcium disodium, causing profound hypocalcemia and triggering the cardiac events that led to his death.

    DISCUSSION:

    In 1991, the CDC recommended using only edetate calcium disodium, not edetate disodium, to children because edetate disodium may induce tetany and possible hypocalcemia as illustrated in this case.

    CONCLUSION:

    The use of chelation therapy in autistic children has not been validated and can have tragic consequences.

    Comment in

    PMID:
    18949650
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Informa Healthcare

      Save items

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk